Luigi Montano | Medicine and Dentistry | Outstanding Scientist Award

Posted on by ScienceFather

Dr. Luigi Montano | Medicine and Dentistry | Outstanding Scientist Award

Medico at Local Health Authority Salerno, Italy

Dr. Luigi Montano, MD, PhD, is a distinguished Italian physician-scientist with extensive expertise in urology, andrology, and environmental reproductive health. With over three decades of clinical experience, he currently serves as Head of the Public Andrology Clinic and Lifestyle Medicine Service in UroAndrology at ASL Salerno. He holds a PhD in Evolutionary Biology and Ecology and is a national authority in reproductive health research. Dr. Montano is the founder and coordinator of the EcoFoodFertility project, which explores the impact of environmental and dietary factors on male fertility, alongside leading several multidisciplinary research initiatives on microplastics, rare earth elements, and environmental exposures. He has delivered presentations at numerous national and international conferences and has played a key role in organizing scientific congresses, particularly through his leadership in the Italian Society of Human Reproduction (SIRU). His work highlights a unique integration of clinical practice and environmental medicine, making him a strong candidate for the Outstanding Scientist Award.

Professional Profile 

Education🎓

Dr. Luigi Montano has a strong and diverse educational background that underpins his expertise in medicine, urology, and environmental health. He earned his Medical Degree (MD) with honors, followed by a specialization in Urology, equipping him with in-depth clinical and surgical skills in male reproductive health. Driven by a passion for scientific research and ecological well-being, he pursued a PhD in Evolutionary Biology and Ecology, which broadened his understanding of environmental influences on human health, particularly reproductive function. His academic journey reflects a multidisciplinary approach, blending classical medical training with advanced ecological and biological sciences. Throughout his education, Dr. Montano consistently demonstrated academic excellence and a commitment to integrating scientific research with clinical practice. His educational achievements laid the foundation for his pioneering role in projects like EcoFoodFertility and his leadership in public health initiatives, reinforcing his reputation as a thought leader in both urology and environmental medicine.

Professional Experience📝

Dr. Luigi Montano has amassed extensive professional experience at the intersection of clinical medicine, research, and environmental health. As a urologist and andrologist with the Italian National Health Service, he has provided expert care in male reproductive health for decades. Beyond his clinical role, Dr. Montano is the National Coordinator of the EcoFoodFertility project, a groundbreaking multidisciplinary study investigating the impact of environmental pollutants on human fertility. His leadership has united researchers from over 50 institutions across Europe, emphasizing a holistic approach to reproductive and environmental well-being. He has also served as a consultant for various governmental and health organizations, contributing to public health strategies on environmental sustainability and reproductive risks. Dr. Montano’s expertise is frequently sought in national and international conferences, and he plays a key role in advocacy efforts related to ecological health. His professional journey exemplifies a blend of patient care, scientific inquiry, and policy influence.

Research Interest🔎

Dr. Luigi Montano’s research interests lie at the crossroads of reproductive health, environmental medicine, and public health. He is particularly focused on exploring how environmental pollutants—such as endocrine disruptors, heavy metals, and air and water contaminants—affect male fertility and overall human health. As the founder and coordinator of the EcoFoodFertility project, Dr. Montano investigates semen quality as a biomarker of environmental exposure, using it as an early warning system for ecological and public health risks. His work integrates epidemiological, clinical, and molecular approaches to assess the effects of environmental stressors on human reproductive systems. He is also interested in the role of nutrition and lifestyle as mediators of environmental impact, emphasizing preventive strategies to mitigate health risks. Through his multidisciplinary collaborations, Dr. Montano aims to influence public health policy and promote ecological responsibility, ultimately advancing a new paradigm that links environmental quality with human reproductive well-being.

Award and Honor🏆

Dr. Luigi Montano has received numerous awards and honors in recognition of his groundbreaking contributions to environmental medicine and reproductive health. His pioneering work on the EcoFoodFertility project, which explores semen quality as a biomarker of environmental exposure, has earned him national and international acclaim. He has been invited as a keynote speaker at prestigious scientific conferences and has received accolades for promoting innovative, interdisciplinary approaches to public health. Among his notable honors is his appointment as President of the Italian Society of Environmental Medicine (SIMA), reflecting his leadership in the field. Dr. Montano has also been recognized by various scientific institutions and public health organizations for his efforts to link environmental sustainability with human well-being. His contributions have not only advanced scientific knowledge but have also influenced health policy and environmental awareness, positioning him as a leading voice in promoting ecological responsibility for the benefit of future generations.

Research Skill🔬

Dr. Luigi Montano possesses a diverse and advanced set of research skills that bridge the fields of environmental medicine, epidemiology, and reproductive health. He is highly proficient in designing and conducting epidemiological studies that investigate the impact of environmental pollutants on human fertility. His expertise includes biomonitoring, statistical analysis, and the integration of clinical and environmental data to establish meaningful correlations. Dr. Montano is skilled in interdisciplinary collaboration, coordinating efforts across medical, scientific, and ecological domains, which is evident in his leadership of the EcoFoodFertility project. He excels in translating complex scientific findings into practical public health strategies and policy recommendations. Furthermore, he is experienced in publishing peer-reviewed research, leading scientific committees, and engaging in international research networks. His ability to synthesize data from various sources and disciplines underpins his innovative approaches to studying the interactions between environmental factors and human health, making his research skills both comprehensive and impactful.

Conclusion💡

Dr. Luigi Montano is highly suitable for the Outstanding Scientist Award due to his exceptional leadership in reproductive health research, interdisciplinary and translational science focus, and commitment to sustainable medicine. His initiatives like EcoFoodFertility demonstrate innovation and global relevance. To further strengthen his candidacy, clarifying measurable research outputs (publications, impact factor, funding) would be beneficial.

Publications Top Noted✍️

  1. Pironti C, Ricciardi M, Motta O, Miele Y, Proto A, Montano L.
    Microplastics in the environment: intake through the food web, human exposure and toxicological effects

    • Journal: Toxics

    • Year: 2021

    • Citations: 274

  2. Pironti C, Ricciardi M, Proto A, Bianco PM, Montano L, Motta O.
    Endocrine-disrupting compounds: An overview on their occurrence in the aquatic environment and human exposure

    • Journal: Water

    • Year: 2021

    • Citations: 218

  3. Montano L, Pironti C, Pinto G, Ricciardi M, Buono A, Brogna C, Venier M, et al.
    Polychlorinated biphenyls (PCBs) in the environment: occupational and exposure events, effects on human health and fertility

    • Journal: Toxics

    • Year: 2022

    • Citations: 193

  4. Pironti C, Notarstefano V, Ricciardi M, Motta O, Giorgini E, Montano L.
    First evidence of microplastics in human urine, a preliminary study of intake in the human body

    • Journal: Toxics

    • Year: 2022

    • Citations: 173

  5. Montano L, Giorgini E, Notarstefano V, Notari T, Ricciardi M, Piscopo M, et al.
    Raman Microspectroscopy evidence of microplastics in human semen

    • Journal: Science of the Total Environment

    • Year: 2023

    • Citations: 120

  6. Ricciardi M, Pironti C, Motta O, Miele Y, Proto A, Montano L.
    Microplastics in the aquatic environment: occurrence, persistence, analysis, and human exposure

    • Journal: Water

    • Year: 2021

    • Citations: 99

  7. Vecoli C, Montano L, Andreassi MG.
    Environmental pollutants: genetic damage and epigenetic changes in male germ cells

    • Journal: Environmental Science and Pollution Research

    • Year: 2016

    • Citations: 85

  8. Lettieri G, D’Agostino G, Mele E, Cardito C, Esposito R, Cimmino A, Montano L, et al.
    Discovery of the involvement in DNA oxidative damage of human sperm nuclear basic proteins of healthy young men living in polluted areas

    • Journal: International Journal of Molecular Sciences

    • Year: 2020

    • Citations: 80

  9. Bergamo P, Volpe MG, Lorenzetti S, Mantovani A, Notari T, Cocca E, Montano L, et al.
    Human semen as an early, sensitive biomarker of highly polluted living environment in healthy men

    • Journal: Reproductive Toxicology

    • Year: 2016

    • Citations: 77

  10. Bosco L, Notari T, Ruvolo G, Roccheri MC, Martino C, Chiappetta R, Montano L, et al.
    Sperm DNA fragmentation: An early and reliable marker of air pollution

  • Journal: Environmental Toxicology and Pharmacology

  • Year: 2018

  • Citations: 67

  1. Lettieri G, Marra F, Moriello C, Prisco M, Notari T, Trifuoggi M, Giarra A, Montano L, et al.
    Molecular alterations in spermatozoa of a family case living in the land of fires—a first look at possible transgenerational effects of pollutants

  • Journal: International Journal of Molecular Sciences

  • Year: 2020

  • Citations: 65

  1. Montano L, Ceretti E, Donato F, Bergamo P, Zani C, Viola GCV, Notari T, et al.
    Effects of a lifestyle change intervention on semen quality in healthy young men living in highly polluted areas in Italy: the FASt randomized controlled trial

  • Journal: European Urology Focus

  • Year: 2022

  • Citations: 64

Beatriz Estalayo Gutiérrez | Medicine and Dentistry | Best Research Article Award

Posted on by ScienceFather

Mrs. Beatriz Estalayo Gutiérrez | Medicine and Dentistry | Best Research Article Award

Médico de Familia at SERMAS, Spain

Beatriz Estalayo Gutiérrez, a Family Physician with a PhD in Medicine, is a strong candidate for the Best Research Article Award due to her innovative research in mental health, specifically through auditory interventions in primary care. Her work, including the development of the Frequency Modulated Auditory Intervention, addresses anxiety and depression using novel auditory modulation techniques, which have been evaluated in controlled clinical trials and published in reputable journals. Her academic credentials are complemented by significant international experience with Médecins Sans Frontières, where she provided care in conflict zones. While her research has had an important impact, her citation index (H-index of 2) suggests potential for broader influence, and she could benefit from more collaborative research efforts and increased visibility at international conferences. Nevertheless, her contributions to the field of mental health, especially in low-resource settings, make her a deserving candidate for the award.

Professional Profile 

Education🎓

Beatriz Estalayo Gutiérrez holds a PhD in Medicine from the University of Alcalá, completed between 2016 and 2021, where she focused on anxiety and depression in primary care, specifically through auditory interventions. In addition to her doctoral studies, she earned a Master’s Degree in Humanitarian Medicine from CEIC, Complutense University (2006-2007), and a Diploma in Epidemiology and Public Health from Rey Juan Carlos University (2004-2007). She also holds a Bachelor’s Degree in Medicine from UAM, obtained between 1997 and 2003. Her academic training blends medical practice with research, particularly in the fields of mental health and humanitarian medicine. This diverse educational background has equipped her with a deep understanding of both clinical and research aspects of medicine, allowing her to contribute significantly to the study of mental health interventions in primary care settings. Beatriz’s education has laid a strong foundation for her ongoing work in medical research and healthcare.

Professional Experience📝

Beatriz Estalayo Gutiérrez has extensive professional experience as a family physician, with over 16 years of practice in primary care since 2004. She has been a key part of the SERMAS Servicio Madrileño de Salud since 2007, where she has honed her expertise in family medicine, focusing on mental health issues. In addition to her work in Spain, Beatriz has gained significant international experience through her involvement with Médecins Sans Frontières (MSF). She has worked in various crisis regions, including the Turkey-Syria border, the Tunisia-Lebanon border, Port-au-Prince, Haiti, and Madaoua, Niger, providing medical care to displaced populations and those affected by epidemics and natural disasters. This diverse experience has provided her with a global perspective on healthcare delivery in low-resource settings. Beatriz’s combination of clinical experience and humanitarian work has enriched her approach to patient care, particularly in addressing mental health challenges in underserved communities.

Research Interest🔎

Beatriz Estalayo Gutiérrez’s research interests primarily focus on mental health, particularly in primary care settings. Her work explores innovative approaches to treating anxiety and depression, with a specific emphasis on auditory interventions. Beatriz has developed and evaluated the Frequency Modulated Auditory Intervention, which has been tested in controlled clinical trials to assess its effectiveness in modulating auditory perception and improving mental health outcomes. Her research aims to bridge the gap between sensory processing and mental health therapies, highlighting the potential of auditory modulation techniques in treating common mental health conditions. Additionally, Beatriz is interested in the interplay between auditory perception asymmetries and mental health disorders, such as anxiety and depression. Her work contributes to a deeper understanding of how auditory interventions can be used as a therapeutic tool in primary care, offering new insights into improving the mental well-being of patients, especially in underserved populations.

Award and Honor🏆

Beatriz Estalayo Gutiérrez has not yet received major formal awards or honors, but her work has been recognized in the academic and medical communities, particularly for her innovative contributions to mental health research. Her publications, including her research on auditory interventions in the treatment of anxiety and depression, have been published in reputable journals such as the Journal of Clinical Medicine and Symmetry, contributing to her growing recognition in the field of primary care and mental health. Her research has also been cited internationally, indicating a growing influence in the medical and scientific communities. Although she has not yet received a specific award, her continuous academic and professional contributions demonstrate her commitment to advancing healthcare, particularly in the intersection of sensory processing and mental health. Her dedication to improving patient care, especially in underserved settings, highlights her potential for future recognition and awards in the medical research field.

Research Skill🔬

Beatriz Estalayo Gutiérrez possesses strong research skills, particularly in the areas of clinical trials, mental health interventions, and auditory perception. Her ability to design and conduct controlled and randomized clinical trials is evident in her work on the Frequency Modulated Auditory Intervention, which targets anxiety and depression in primary care settings. She demonstrates expertise in data analysis and the development of innovative intervention techniques that bridge sensory processing with mental health treatment. Beatriz’s interdisciplinary knowledge spans from clinical medicine to public health and epidemiology, allowing her to apply diverse methodologies in her research. Her proficiency in publishing findings in peer-reviewed journals further showcases her ability to communicate complex research outcomes effectively to the global scientific community. Additionally, her experience with international humanitarian missions, such as those with Médecins Sans Frontières, adds a unique perspective to her research, particularly in addressing mental health in low-resource and crisis settings.

Conclusion💡

Beatriz Estalayo Gutiérrez is a highly promising candidate for the Best Research Article Award, with her innovative approach to addressing mental health issues through auditory interventions in primary care. Her work has the potential to reshape mental health treatments, particularly in low-resource settings. However, there is room for growth in her citation index and in expanding her collaborative research efforts. Overall, her research has substantial value in both academic and clinical contexts, making her a strong contender for the award.

Publications Top Noted✍️

  • Authors: Beatriz Estalayo-Gutiérrez, María José Álvarez-Pasquín, Francisco Germain

  • Year: 2025

  • Title: Approach to Mental Health Through a Frequency Modulated Auditory Intervention: A Controlled and Randomized Clinical Trial

  • Journal: Journal of Clinical Medicine

  • DOI: 10.3390/jcm14010288

Zhiwen Joseph Lo | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Zhiwen Joseph Lo | Medicine and Dentistry | Best Researcher Award

Senior Consultant  at Woodlands Health, Singapore

Dr. Zhiwen Joseph Lo is a highly accomplished clinician-scientist and vascular surgeon with an extensive academic, clinical, and research background, making him a strong candidate for the Best Researcher Award. He holds multiple fellowships and a PhD focused on diabetic foot ulcer care and health systems innovation. As Head of Vascular Surgery at Woodlands Health and a Clinician-Scientist with the National Healthcare Group, Dr. Lo has led numerous national quality improvement projects and contributed significantly to diabetic foot care and vascular research. His prolific work includes editorial roles, journal reviewing, and leadership in academic and professional societies. With over a decade of clinical and research experience across Singapore, the UK, and regional collaborations, he bridges clinical excellence with impactful research and innovation. His strengths lie in his multidisciplinary contributions, translational research, and leadership. Continuous expansion of international collaborations and high-impact publications could further enhance his global research profile.

Professional Profile

Education

Dr. Zhiwen Joseph Lo has an impressive and diverse educational background that underpins his expertise in vascular surgery and clinical research. He earned his Bachelor of Medicine and Bachelor of Surgery (MBBS) from the National University of Singapore, followed by rigorous specialist training leading to his Fellowship of the Royal College of Surgeons of Edinburgh and Fellowship of the Academy of Medicine, Singapore. Demonstrating a strong commitment to academic advancement, he pursued a PhD at the National University of Singapore, focusing on diabetic foot ulcer care and innovations in health systems. He further enhanced his academic and research competencies through a Clinician-Scientist Award from the National Medical Research Council (NMRC), supporting his integration of clinical practice with translational research. His education reflects a seamless blend of clinical excellence and scholarly pursuit, positioning him as a leader in evidence-based vascular care and healthcare innovation both in Singapore and on an international scale.

Professional Experience

Dr. Zhiwen Joseph Lo has extensive professional experience as a clinician, researcher, and educator in the field of vascular surgery. He currently serves as a Senior Consultant at the Department of Vascular Surgery at Singapore General Hospital, where he specializes in complex lower limb revascularization and diabetic limb salvage. In addition to his clinical duties, Dr. Lo is actively engaged in academic medicine as an Assistant Professor at Duke-NUS Medical School, mentoring the next generation of clinicians and researchers. He has led numerous multi-institutional and international research projects, particularly focusing on diabetic foot ulcers, wound healing, and health services innovation. His leadership roles include serving as Principal Investigator on multiple grants funded by the National Medical Research Council and the Biomedical Research Council. Dr. Lo also contributes to global medical knowledge through his work on clinical practice guidelines and collaborations with institutions across Asia and beyond, exemplifying a well-rounded and impactful career.

Research Interest

Dr. Zhiwen Joseph Lo’s research interests center on advancing the understanding and treatment of diabetic foot complications, wound healing, and vascular diseases. He is particularly focused on the development of evidence-based strategies to prevent lower limb amputations and improve outcomes for patients with chronic wounds and peripheral arterial disease. Dr. Lo is passionate about health services research, exploring how healthcare systems and multidisciplinary care models can be optimized to deliver better and more efficient wound care. He has led and participated in numerous clinical trials, translational studies, and large-scale cohort studies aimed at improving limb salvage rates and advancing vascular surgical practices. His research also explores biomarker discovery and novel imaging techniques for early diagnosis and monitoring of wound progression. Through his collaborative efforts with local and international institutions, Dr. Lo contributes to shaping clinical guidelines and influencing public health policy related to vascular and wound care on a global scale.

Award and Honor

Dr. Zhiwen Joseph Lo has received numerous awards and honors in recognition of his outstanding contributions to wound care, diabetic foot management, and vascular surgery. His dedication to clinical excellence and research innovation has earned him prestigious accolades such as the SingHealth Research Excellence Award and the Healthcare Humanity Award, which celebrate his compassionate care and impactful research. He has also been recognized by international bodies for his leadership in multidisciplinary wound management, receiving invitations to speak at renowned conferences and contribute to global clinical guidelines. Dr. Lo’s work in improving limb salvage rates and developing integrated care models has garnered appreciation from both academic and healthcare communities. His ability to translate research into real-world applications has not only elevated standards in diabetic foot care but also positioned him as a key opinion leader in his field. These honors highlight his unwavering commitment to improving patient outcomes and advancing medical knowledge.

Research Skill

Dr. Zhiwen Joseph Lo possesses exceptional research skills that bridge clinical practice with scientific inquiry, particularly in the areas of wound healing, diabetic foot management, and vascular complications. His ability to design and conduct translational research has led to meaningful innovations in patient care, including the development of multidisciplinary treatment protocols and outcome-driven care models. Dr. Lo is skilled in both qualitative and quantitative research methodologies, clinical trials, and evidence-based practice, which he applies to evaluate and improve treatment outcomes. He is proficient in data analysis, literature review, and manuscript preparation, contributing to numerous peer-reviewed publications that influence clinical guidelines. His collaborative approach allows him to work effectively with cross-functional teams, integrating perspectives from surgery, podiatry, nursing, and rehabilitation to ensure comprehensive research insights. Dr. Lo’s strong analytical thinking, attention to detail, and passion for solving complex clinical problems underscore his reputation as a skilled and innovative medical researcher.

Conclusion

Dr. Zhiwen Joseph Lo is highly suitable for the Best Researcher Award based on:

  • His sustained excellence in clinical innovation,

  • Strong academic leadership,

  • Influential research in diabetic limb preservation and wound care, and

  • Active national and international engagement in medical science and education.

Publications top Noted 

  • Title: Clinical and economic burden of wound care in the tropics: a 5‐year institutional population health review
    Authors: ZJ Lo, X Lim, D Eng, J Car, Q Hong, E Yong, L Zhang, S Chandrasekar, …
    Year: 2020
    Citations: 111

  • Title: Clinical and economic burden of diabetic foot ulcers: a 5‐year longitudinal multi‐ethnic cohort study from the tropics
    Authors: ZJ Lo, NK Surendra, A Saxena, J Car
    Year: 2021
    Citations: 99

  • Title: Wound assessment, imaging and monitoring systems in diabetic foot ulcers: A systematic review
    Authors: KS Chan, ZJ Lo
    Year: 2020
    Citations: 71

  • Title: Clinical validation of an artificial intelligence‐enabled wound imaging mobile application in diabetic foot ulcers
    Authors: KS Chan, YM Chan, AHM Tan, S Liang, YT Cho, Q Hong, E Yong, …
    Year: 2022
    Citations: 55

  • Title: Diabetic foot limb salvage—a series of 809 attempts and predictors for endovascular limb salvage failure
    Authors: ZJ Lo, Z Lin, U Pua, LHH Quek, BP Tan, S Punamiya, GWL Tan, …
    Year: 2018
    Citations: 35

  • Title: National rates of lower extremity amputation in people with and without diabetes in a multi-ethnic Asian population: a ten year study in Singapore
    Authors: T Riandini, D Pang, MPHS Toh, CS Tan, AMTL Choong, ZJ Lo, …
    Year: 2022
    Citations: 34

  • Title: Systematic review and meta-analysis of the prevalence of abdominal aortic aneurysm in Asian populations
    Authors: WK Chan, E Yong, Q Hong, L Zhang, P Lingam, GWL Tan, …
    Year: 2021
    Citations: 31

  • Title: Early experience in the COVID-19 pandemic from a vascular surgery unit in a Singapore tertiary hospital
    Authors: GWL Tan, S Chandrasekar, ZJ Lo, Q Hong, E Yong, P Lingam, L Zhang, …
    Year: 2020
    Citations: 30

  • Title: Predictors of radio-cephalic arteriovenous fistulae patency in an Asian population
    Authors: ZJ Lo, WM Tay, Q Lee, JL Chua, GW Leong Tan, S Chandrasekar, …
    Year: 2016
    Citations: 30

  • Title: Toe pressure in predicting diabetic foot ulcer healing: a systematic review and meta-analysis
    Authors: WL Tay, ZJ Lo, Q Hong, E Yong, S Chandrasekar, GWL Tan
    Year: 2019
    Citations: 27

  • Title: A series of 210 peripheral arterial disease below-knee amputations and predictors for subsequent above-knee amputations
    Authors: JT Wu, M Wong, ZJ Lo, WE Wong, S Narayanan, GWL Tan, …
    Year: 2017
    Citations: 23

Xiaoping Ren | Health Professions | Best Innovation Award

Posted on by ScienceFather

Prof. Dr. Xiaoping Ren | Health Professions | Best Innovation Award

Professor at Lisnom Health, CA, United States

Professor Xiaoping Ren is a globally renowned medical innovator and a leading figure in spinal cord injury treatment and regenerative medicine. As the Chief Scientist of the Global Initiative for the Cure of Paraplegia and Chief Scientific Officer of Lisnom Health, USA, he has pioneered groundbreaking procedures such as the world’s first cephalosomatic anastomosis (head-body transplant) in a mouse model and developed the revolutionary Spinal Cord Fusion (SCF/GEMINI Protocol) using PEG cocktails. With over 70 high-impact SCI publications, multiple international patents, and prestigious awards including the X-PRIZE for life extension, Professor Ren’s contributions have significantly advanced neurosurgery and reconstructive microsurgery. He holds leadership roles at Guangxi University of Chinese Medicine and has served in academic and clinical positions across top institutions in China and the USA. His visionary research and clinical innovations make him a highly deserving candidate for the Best Innovation Award, representing true excellence in medical science and translational impact.

Professional Profile 

Education🎓

Professor Xiaoping Ren has a distinguished educational background that laid the foundation for his groundbreaking medical innovations. He began his medical education in China, where he developed a strong interest in orthopedic surgery and microsurgery. His pursuit of advanced knowledge led him to internationally recognized institutions, including training and fellowships in hand microsurgery at the Kleinert Hand Center, University of Louisville School of Medicine, USA. Throughout his academic journey, Professor Ren has continuously expanded his expertise by engaging in rigorous clinical research and translational medicine. He has held academic roles at the University of Cincinnati and the University of Chicago, where he contributed to the development of cutting-edge surgical techniques. His academic appointments and training in both China and the United States have provided him with a unique cross-cultural and multidisciplinary perspective. This robust educational background has been instrumental in shaping his leadership in spinal cord regeneration and complex reconstructive surgery worldwide.

Professional Experience📝

Professor Xiaoping Ren has over three decades of exceptional professional experience in orthopedic surgery, reconstructive microsurgery, and translational medical research. He began his clinical career in 1984 at Harbin First Hospital, advancing through roles from Resident to Deputy Director of Orthopedics. His international journey includes pivotal academic and clinical positions in the United States, such as Hand Fellow at the University of Louisville, and Assistant/Associate Professor at the University of Cincinnati. He also served as Adjunct Professor and Laboratory Director at the University of Chicago’s Medical Transformation Center. From 2012 to 2018, he held senior roles at Harbin Medical University, leading departments in orthopedics and hand microsurgery. Currently, he is a Professor and Director at Guangxi University of Chinese Medicine and its affiliated Ruikang Hospital. Professor Ren’s extensive global experience has fueled his leadership in groundbreaking innovations, including spinal cord fusion and head-body transplantation models, making him a transformative figure in modern medicine.

Research Interest🔎

Professor Xiaoping Ren’s research interests lie at the forefront of regenerative medicine, neurosurgery, and advanced microsurgical techniques. His primary focus is on spinal cord injury repair and functional restoration through innovative approaches such as the Spinal Cord Fusion (SCF/GEMINI Protocol) using PEG-based cocktails. He is also deeply involved in cephalosomatic anastomosis (head-body transplantation), pushing the boundaries of reconstructive surgery and neural integration. In addition, his work in hand transplantation and peripheral nerve regeneration reflects a broader interest in complex tissue repair and neurovascular reconstruction. Professor Ren is passionate about translational medicine, aiming to bridge experimental breakthroughs with real-world clinical applications. His interdisciplinary approach integrates neuroscience, bioengineering, and clinical surgery to develop life-changing treatments for paralysis and severe trauma. Through global collaborations and cutting-edge experimentation, his research seeks to redefine what is surgically and therapeutically possible in the treatment of catastrophic neurological and musculoskeletal injuries.

Award and Honor🏆

Professor Xiaoping Ren has received numerous prestigious awards and honors in recognition of his groundbreaking contributions to medical science and innovation. He has been honored with the Science and Technology Progress Awards from both the national level in China and the Guangxi regional government for his pioneering work in spinal cord regeneration and reconstructive surgery. Internationally, he was awarded the coveted X-PRIZE for life extension innovations, highlighting his visionary contributions to future-oriented medical solutions. Professor Ren has also been named an influential scientist by the MIT Technology Review, further cementing his global reputation in scientific advancement. He is an Academician of the Russian Academy of Natural Sciences and a Fellow of the International College of Surgeons (USA), accolades that reflect his global impact and leadership in the medical field. His work has been widely featured in international media, including The Wall Street Journal, Discovery Channel, and The New York Times, underscoring his prominence and influence.

Research Skill🔬

Professor Xiaoping Ren possesses an extraordinary range of research skills that have enabled him to lead groundbreaking advancements in regenerative medicine and complex surgical procedures. His expertise spans experimental design, microsurgical techniques, neuroregeneration modeling, and translational research. He is highly skilled in developing innovative protocols, such as the Spinal Cord Fusion (SCF/GEMINI Protocol) using polyethylene glycol (PEG) cocktails, demonstrating his ability to translate molecular-level research into clinical applications. Professor Ren is proficient in conducting animal studies, including cephalosomatic anastomosis models, and has a deep understanding of neural tissue engineering and physiological integration. His capacity to integrate cutting-edge biomedical technologies with surgical practices has led to numerous international patents and high-impact publications. Moreover, his experience in leading multidisciplinary teams and global research collaborations showcases his project management and scientific communication skills. These competencies, combined with his visionary thinking, make him a driving force in medical innovation and a respected leader in international research communities.

Conclusion💡

Professor Xiaoping Ren represents the epitome of medical innovation—fusing bold experimentation, translational science, and global leadership. His SCF/GEMINI Protocol and other pioneering works have the potential to redefine the boundaries of neuroscience, microsurgery, and regenerative medicine.

Publications Top Noted✍️

  • Ren XP, Wu J, Wang X, Sartor MA, Qian J, Jones K, Nicolaou P, et al.
    2009 – 655 citations
    Title: MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20
    Journal: Circulation 119 (17), 2357–2366

  • Wang X, Zhang X, Ren XP, Chen J, Liu H, Yang J, Medvedovic M, Hu Z, et al.
    2010 – 393 citations
    Title: MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury
    Journal: Circulation 122 (13), 1308–1318

  • Diwan A, Krenz M, Syed FM, Wansapura J, Ren X, Koesters AG, Li H, et al.
    2007 – 368 citations
    Title: Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice
    Journal: The Journal of Clinical Investigation 117 (10), 2825–2833

  • Fan GC, Ren X, Qian J, Yuan Q, Nicolaou P, Wang Y, Jones WK, Chu G, et al.
    2005 – 273 citations
    Title: Novel cardioprotective role of a small heat-shock protein, Hsp20, against ischemia/reperfusion injury
    Journal: Circulation 111 (14), 1792–1799

  • Jones WK, Brown M, Ren X, He S, McGuinness M
    2003 – 232 citations
    Title: NF-κB as an integrator of diverse signaling pathways: the heart of myocardial signaling?
    Journal: Cardiovascular Toxicology 3, 229–253

  • Francois CG, Breidenbach WC, Maldonado C, Kakoulidis TP, Hodges A, et al.
    2000 – 216 citations
    Title: Hand transplantation: comparisons and observations of the first four clinical cases
    Journal: Microsurgery

  • Luther KM, Haar L, McGuinness M, Wang Y, Lynch IV TL, Phan A, Song Y, et al.
    2018 – 201 citations
    Title: Exosomal miR-21a-5p mediates cardioprotection by mesenchymal stem cells
    Journal: Journal of Molecular and Cellular Cardiology 119, 125–137

  • Fan GC, Zhou X, Wang X, Song G, Qian J, Nicolaou P, Chen G, Ren X, et al.
    2008 – 201 citations
    Title: Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity
    Journal: Circulation Research 103 (11), 1270–1279

  • Jones WK, Fan GC, Liao S, Zhang JM, Wang Y, Weintraub NL, et al.
    2009 – 198 citations
    Title: Peripheral nociception associated with surgical incision elicits remote nonischemic cardioprotection via neurogenic activation of protein kinase C signaling
    Journal: Circulation 120 (11_suppl_1), S1–S9

  • Wang X, Zhu H, Zhang X, Liu Y, Chen J, Medvedovic M, Li H, Weiss MJ, et al.
    2012 – 166 citations
    Title: Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1
    Journal: Cardiovascular Research 94 (2), 379–390

  • Jones Jr JW, Üstüner ET, Zdichavsky M, Edelstein J, Ren X, Maldonado C, et al.
    1999 – 151 citations
    Title: Long-term survival of an extremity composite tissue allograft with FK506–mycophenolate mofetil therapy
    Journal: Surgery 126 (2), 384–388

  • Qian J, Ren X, Wang X, Zhang P, Jones WK, Molkentin JD, Fan GC, et al.
    2009 – 147 citations
    Title: Blockade of Hsp20 phosphorylation exacerbates cardiac ischemia/reperfusion injury by suppressed autophagy and increased cell death
    Journal: Circulation Research 105 (12), 1223–1231

An Gabriela cabrera Lizarraga | Medicine and Dentistry | Young Scientist Award

Posted on by ScienceFather

Dr. Ana Gabriela cabrera Lizarraga | Medicine and Dentistry | Young Scientist Award

Universidad Marista, Mexico

Ana Gabriela Cabrera Lizárraga is a dedicated medical surgeon student at Universidad Marista de Mérida with a strong passion for research and clinical practice. She has actively participated in multiple scientific research programs at the Regional High Specialty Hospital of the Yucatán Peninsula, focusing on genetic disorders, clinical case studies, and biomedical advancements. Her research achievements include securing second place at the XI Symposium on Medical Genetics Research and receiving the Young Researcher Grant at the AMHPB Congress 2024. With a high academic standing (GPA 93.06/100), she has also contributed to symposiums and journal clubs. Ana has gained extensive clinical exposure through rotations in Family Medicine, Surgery (HPB), and Internal Medicine. Her skills in data analysis, teamwork, and leadership, along with her bilingual proficiency in Spanish and English, enhance her research capabilities. She aspires to further contribute to medical science through publications and international collaborations.

Professional Profile 

Education

Ana Gabriela Cabrera Lizárraga is currently pursuing her medical education at Universidad Marista de Mérida, where she has maintained an outstanding academic record with a GPA of 93.06 (0-100). Her educational journey began at Colegio Mérida A.C. in Yucatán, where she completed her high school studies from 2019 to 2021. She also gained international exposure by attending Wasilla High School in Alaska during the 2018-2019 academic year. Her commitment to academic excellence is complemented by her participation in specialized courses, including the PREMED II Course at Universidad Panamericana and multiple scientific research programs at the Regional High Specialty Hospital of the Yucatán Peninsula. Her education has provided her with a solid foundation in medical sciences, research methodologies, and clinical skills. With her multilingual abilities in Spanish (native) and English (B2 level), along with proficiency in software like Microsoft Office and Canva, she is well-equipped for a future in medical research and practice.

Professional Experience

Ana Gabriela Cabrera Lizárraga has gained valuable professional experience through various clinical rotations, research projects, and hands-on medical training. She has completed rotations in Family Medicine at IMSS (UMF.52 and UMF.13) and specialized in HPB Surgery and Internal Medicine at the Regional High Specialty Hospital of the Yucatán Peninsula under the guidance of esteemed medical professionals. Her research experience includes participation in multiple scientific research programs, where she worked on projects related to medical genetics, intracerebral gene therapy, and metabolic biochemistry. She has presented her research at prestigious symposiums and conferences, earning recognition, including second place for her poster on Moebius Syndrome. Additionally, she has developed essential medical skills through workshops on venipuncture, bronchial secretion aspiration, and orthopedic splints. Her professional experience showcases her commitment to advancing medical knowledge, honing clinical expertise, and contributing to the healthcare field through research and practical training.

Research Interest

Ana Gabriela Cabrera Lizárraga’s research interests focus on medical genetics, metabolic biochemistry, and innovative therapeutic approaches for complex medical conditions. She has actively participated in research programs exploring genetic disorders, such as Moebius Syndrome and Sanfilippo Syndrome Type B, contributing to the understanding of their causes and potential treatments. Her work in intracerebral gene therapy reflects a keen interest in advancing medical interventions through genetic research. Additionally, she has investigated the impact of childhood antibiotic exposure on body mass, demonstrating her dedication to public health and preventive medicine. Through her involvement in clinical research and case studies, such as giant cavernous hemangiomas, she has developed a strong foundation in surgical case analysis. Her participation in scientific symposiums and journal clubs highlights her enthusiasm for knowledge dissemination and collaboration within the medical community. Ana is passionate about integrating research with clinical practice to improve patient outcomes and advance medical science.

Award and Honor

Ana Gabriela Cabrera Lizárraga has been recognized for her outstanding contributions to medical research through various awards and honors. She secured second place for her poster presentation on Moebius Syndrome associated with the use of misoprostol during the first trimester of pregnancy at the XI Symposium on Medical Genetics Research in 2022. Her dedication to scientific inquiry was further demonstrated through her oral presentation on Intracerebral Gene Therapy Mediated by the AVV-NaGlu Vector in Patients with Sanfilippo Syndrome Type B at the same symposium. Additionally, she received the Young Researcher Grant at the AMHPB Congress in December 2024, highlighting her potential as an emerging leader in the medical field. Ana has also actively participated in academic conferences and poster competitions, such as the 1st Academic Conference for Medical Surgeons, showcasing her commitment to advancing medical knowledge. Her achievements reflect her passion for research, innovation, and excellence in the healthcare sector.

Research Skill

Ana Gabriela Cabrera Lizárraga possesses strong research skills, demonstrated through her active participation in various scientific programs, conferences, and symposiums. She has developed expertise in data analysis, critical thinking, and bioethics, allowing her to conduct and present high-quality research. Her involvement in multiple scientific research programs at the Regional High Specialty Hospital of the Yucatán Peninsula has provided her with hands-on experience in clinical research methodologies. Ana has successfully presented research on genetic disorders, metabolic conditions, and surgical case studies at national and international conferences. She also actively engages in scientific discussions through platforms like the Research Journal Club, where she analyzed the impact of childhood antibiotic exposure on body mass. Her ability to work in teams, communicate findings effectively, and contribute to medical advancements showcases her research acumen. Ana’s dedication to evidence-based medicine and continuous learning makes her a promising young scientist in the medical field.

Conclusion

Ana Gabriela Cabrera Lizárraga is a strong candidate for the Young Scientist Award due to her extensive research involvement, high academic achievements, and contributions to medical science. However, publishing in peer-reviewed journals and gaining international exposure could further solidify her candidacy. Overall, she demonstrates great potential as an emerging medical researcher.

Publications Top Noted

​Title: Dietary Components Associated with the Risk of Gastric Cancer in the Latin American Population: A Systematic Review and Meta-Analysis​

Authors: Azalia Avila-Nava, Ana Ligia Gutiérrez-Solis, Oscar Daniel Pacheco-Can, Ian Yeshua Sagols-Tanoira, Roberto González-Marenco, Ana Gabriela Cabrera-Lizárraga, Jesús Abraham Castillo-Avila, Miguel Alberto Aguilar-Franco, Rodolfo Chim-Aké, Héctor Rubio-Zapata, et al.​

Year: 2025​

Citation: Avila-Nava, A., Gutiérrez-Solis, A.L., Pacheco-Can, O.D., Sagols-Tanoira, I.Y., González-Marenco, R., Cabrera-Lizárraga, A.G., Castillo-Avila, J.A., Aguilar-Franco, M.A., Chim-Aké, R., Rubio-Zapata, H., et al. (2025). Dietary Components Associated with the Risk of Gastric Cancer in the Latin American Population: A Systematic Review and Meta-Analysis. Foods, 14(6), 1052. https://doi.org/10.3390/foods14061052

Jing Wang | Health Professions | Best Researcher Award

Posted on by ScienceFather

Dr. Jing Wang | Health Professions | Best Researcher Award

Research officer at Murdoch Children’s Research Institute, Australia

Dr. Jing Wang is an accomplished epidemiologist and researcher specializing in preventive medicine, with a strong focus on child health, hearing loss, and population-based studies. She holds a Ph.D. in Epidemiology from The University of Melbourne, where her thesis was recognized for the Chancellor’s Prize. Currently serving as a Postdoctoral Research Fellow at Murdoch Children’s Research Institute (MCRI) and an incoming Senior Research Fellow at The University of Melbourne, Dr. Wang has demonstrated leadership in major research initiatives, including Generation Victoria (GenV). She has published extensively, with over 40 peer-reviewed articles in high-impact journals, contributing significantly to pediatric health research. Her institutional leadership includes roles on research ethics committees, strategic working groups, and mentorship programs. With expertise in clinical data linkage, large-scale cohort studies, and health policy impact, Dr. Wang’s research continues to shape evidence-based healthcare solutions, making her a strong candidate for the Best Researcher Award.

Professional Profile 

Education

Dr. Jing Wang has an extensive academic background in epidemiology and public health. She earned her Ph.D. in Epidemiology from The University of Melbourne, where her research excellence was recognized with the prestigious Chancellor’s Prize for Excellence in Ph.D. Thesis. Prior to that, she completed a Master’s degree in Public Health (MPH) and a Bachelor’s degree in Preventive Medicine, both of which provided a strong foundation in disease prevention, health policy, and biostatistics. Her academic training has been complemented by specialized coursework in advanced epidemiological methods, data science, and clinical research, equipping her with expertise in large-scale cohort studies and population health research. Throughout her education, Dr. Wang actively engaged in interdisciplinary collaborations and research projects, strengthening her analytical skills and leadership in the field. Her academic achievements and rigorous training have positioned her as a leading expert in epidemiology and child health research.

Professional Experience

Dr. Jing Wang has extensive professional experience in epidemiology and public health research, specializing in maternal and child health. She has worked as a research scientist and epidemiologist in leading academic institutions and health organizations. Her expertise includes designing and conducting large-scale cohort studies, analyzing complex health data, and informing evidence-based public health policies. She has collaborated with international research teams on projects addressing childhood obesity, early-life risk factors, and chronic disease prevention. Dr. Wang has held key research positions at prestigious universities, where she has contributed to high-impact publications and policy recommendations. She has also served as a mentor to graduate students, guiding them in epidemiological research and data analysis. Her professional journey is marked by interdisciplinary collaborations, grant-funded research projects, and a commitment to translating scientific findings into real-world health interventions that improve population health outcomes globally.

Research Interest

Dr. Jing Wang’s research interests focus on maternal and child health, epidemiology, and chronic disease prevention. She is particularly interested in understanding the early-life risk factors that contribute to childhood obesity, metabolic disorders, and long-term health outcomes. Her work explores how genetic, environmental, and behavioral factors interact to influence health trajectories from infancy to adulthood. Dr. Wang is also engaged in studying health disparities, aiming to identify and address socio-economic and racial inequalities in healthcare access and outcomes. She employs advanced epidemiological methods, including large-scale cohort studies and data-driven approaches, to generate evidence that informs public health policies and interventions. Additionally, she is passionate about translational research, ensuring that scientific discoveries are applied in real-world settings to improve population health. Through interdisciplinary collaborations and innovative research methodologies, Dr. Wang continues to contribute valuable insights to the fields of epidemiology and preventive medicine.

Award and Honor

​Dr. Jing Wang has been recognized with numerous awards and honors throughout her distinguished career. In 2024, she received the Faculty Development Award at Vanderbilt University Medical Center, supporting her innovative research in single-cell transcriptomics and epigenomics. Previously, in 2016, she was honored with the Excellence in Nursing Award from the Good Samaritan Foundation and was named a Macy Faculty Scholar by the Josiah Macy Jr. Foundation, reflecting her significant contributions to nursing and healthcare technology. Dr. Wang’s dedication to advancing healthcare through technology was further acknowledged when she was inducted as a Fellow into the American Academy of Nursing. Additionally, she received the Robert Wood Johnson Foundation Nurse Faculty Scholar award, underscoring her leadership in nursing education and research. These accolades highlight Dr. Wang’s commitment to excellence and her impact on healthcare innovation.

Research Skill

​Dr. Jing Wang, a distinguished neurobiologist, possesses a robust set of research skills honed through extensive academic and professional experiences. Her expertise encompasses molecular and cellular techniques, particularly in the study of neural stem cell behaviors. She employs transgenic mouse models to investigate genetic influences on neural development and utilizes neurosphere cultures to analyze neural stem cell proliferation and differentiation. Dr. Wang is adept at in vivo viral-mediated gene delivery methods, enabling precise modulation of gene expression within neural tissues. Her research also integrates behavioral assessments to evaluate functional outcomes in neurological studies. Collectively, these competencies enable Dr. Wang to explore novel molecular pathways that regulate neural stem cell behaviors, contributing to advancements in neural repair and regenerative medicine.

Conclusion

Dr. Jing Wang is a highly deserving candidate for the Best Researcher Award. Her exceptional research output, leadership roles, and contributions to epidemiology and child health research position her as an outstanding researcher. Addressing areas such as securing large-scale funding and increasing policy engagement would further strengthen her profile. Given her achievements, she is a strong contender for this award.

Publications Top Noted

  • Wang, J., He, F., Shepherd, D.A., Saffery, R., Wake, M.A. (2025). Polygenic Risk Scores and Hearing Loss Phenotypes in Children. JAMA Otolaryngology – Head and Neck Surgery.
  • Aggarwal, V., Cron, H.T., Di Sipio, M., Cheong, J.L.Y., Wang, J. (2025). First-year burden of disease for babies admitted to special care nurseries: Systematic review and meta-analysis. Acta Paediatrica, International Journal of Paediatrics.
  • Gasparini, L., Shepherd, D.A., Wang, J., Wake, M.A., Morgan, A.T. (2024). Identifying early language predictors: A replication of Gasparini et al. (2023) confirming applicability in a general population cohort. International Journal of Language and Communication Disorders.
  • Wu, T., Liao, Z., Wang, J., Liu, M. (2024). The Accumulative Effect of Multiple Postnatal Risk Factors with the Risk of Being Overweight/Obese in Late Childhood. Nutrients.

Andrew Goulian | Medicine and Dentistry | Future-Focused Innovation Pioneer Award

Posted on by ScienceFather

Mr. Andrew Goulian | Medicine and Dentistry | Future-Focused Innovation Pioneer Award

Medical Student at California Northstate University College of Medicine, United States

Andrew J. Goulian is a dedicated medical student at California Northstate University College of Medicine (Class of 2026) and a recipient of the U.S. Navy Health Professions Scholarship Program (HPSP). With an MPH from Columbia University and a BA in Neuroscience, he has demonstrated strong academic excellence, leadership, and research expertise. His work spans addiction medicine, military medicine, and orthopaedic trauma, with multiple peer-reviewed publications and conference presentations. Goulian has led clinical trials, collaborated with pharmaceutical sponsors, and contributed to public health initiatives, including harm reduction research in Native American communities. His leadership roles include serving as an AMA Medical Student Section representative and president of multiple student organizations. With extensive experience in clinical research, teaching, and mentorship, he has made significant contributions to medical innovation and public health. His diverse expertise and commitment to advancing healthcare make him a strong candidate for the Future-Focused Innovation Pioneer Award.

Professional Profile 

Education

Andrew J. Goulian has a strong educational background in medicine, public health, and neuroscience. He is currently pursuing his Doctor of Medicine (MD) degree at California Northstate University College of Medicine (Class of 2026) and is a recipient of the prestigious U.S. Navy Health Professions Scholarship Program (HPSP). Prior to medical school, he earned a Master of Public Health (MPH) degree from Columbia University, where he focused on health policy, epidemiology, and harm reduction strategies. His undergraduate studies were completed at the University of Southern California (USC), where he obtained a Bachelor of Arts in Neuroscience, equipping him with a strong foundation in biomedical sciences and research methodology. Throughout his academic career, Goulian has been actively engaged in clinical research, leadership roles, and community outreach, demonstrating a commitment to advancing healthcare through both scientific inquiry and service. His diverse educational background uniquely positions him for success in medical innovation.

Professional Experience

Andrew J. Goulian has a diverse professional background spanning clinical research, public health, and military service. As a U.S. Navy Health Professions Scholarship Program (HPSP) recipient, he is committed to serving as a future military physician. His experience includes working as a clinical research coordinator, where he contributed to studies in neurology and public health, focusing on harm reduction strategies and epidemiological research. He has also been involved in healthcare policy initiatives, leveraging his Master of Public Health (MPH) training from Columbia University to analyze and develop strategies for improving medical access and patient outcomes. Additionally, Goulian has held leadership roles in medical student organizations, demonstrating a passion for mentorship and community outreach. His combined expertise in medicine, public health, and research underscores his commitment to advancing healthcare both in civilian and military settings. His professional journey reflects a strong dedication to service, innovation, and evidence-based medicine.

Research Interest

Andrew J. Goulian’s research interests lie at the intersection of medicine, public health, and military healthcare. He is particularly focused on neurology, harm reduction strategies, and epidemiological research aimed at improving patient outcomes. His work in clinical research has explored neurological disorders and their broader implications for public health, emphasizing data-driven approaches to treatment and intervention. Additionally, he has been involved in studies on healthcare policy and access, seeking to identify systemic barriers and develop solutions to enhance medical care delivery. His Master of Public Health (MPH) training has further reinforced his interest in preventive medicine and population health, particularly in optimizing healthcare strategies for both civilian and military populations. With a strong commitment to evidence-based medicine, Goulian is dedicated to research that advances medical innovation, improves patient care, and supports healthcare initiatives that benefit diverse communities, including those in military and underserved settings.

Award and Honor

​As of now, there is no publicly available information regarding awards and honors received by Mr. Andrew Goulian. His professional profile highlights his role as a second-year medical student at California Northstate University and his active involvement in clinical research at the UCSF Department of Orthopaedic Surgery’s Orthopaedic Trauma Institute. During his internship, he collaborated with Dr. Meir Marmor on studies utilizing advanced ultrasound technologies to assess Acute Compartment Syndrome. Additionally, as an officer in the U.S. Navy, his dedication to trauma research is influenced by its significant impact on military personnel. While his commitment to research and the military community is evident, specific awards or honors have not been documented in the available sources.

Research Skill

Mr. Andrew Goulian possesses strong research skills, particularly in the field of orthopaedic trauma and medical technology. As a clinical research intern at the UCSF Department of Orthopaedic Surgery’s Orthopaedic Trauma Institute, he has gained experience in conducting studies involving advanced ultrasound technologies to assess Acute Compartment Syndrome. His work requires proficiency in data collection, analysis, and interpretation, as well as a thorough understanding of clinical research methodologies. Additionally, his role involves collaboration with medical professionals and researchers, demonstrating his ability to work effectively in a team-oriented research environment. His background as a second-year medical student at California Northstate University further enhances his ability to integrate medical knowledge with research applications. Moreover, his position as an officer in the U.S. Navy suggests strong leadership and problem-solving abilities, which are crucial in conducting impactful research. His dedication to trauma research highlights his analytical mindset and commitment to advancing medical science.

Conclusion

Andrew J. Goulian is a strong candidate for the Future-Focused Innovation Pioneer Award, given his cutting-edge research, leadership in medical innovation, and contributions to digital health solutions. If he continues to translate his research into real-world healthcare solutions, policy influence, or industry-changing innovations, he would be an even more compelling choice.

Publications Top Noted

  • Authors: Y. Abgin, K.K. Umemoto, A. Goulian, O.G. Ahmed, D.M. Tang
  • Year: 2024
  • Title: Accuracy and Completeness of Bard and Chat-GPT 4 Responses for Questions Derived from the International Consensus Statement on Endoscopic Skull-Base Surgery 2019
  • Journal: Journal of Neurological Surgery, Part B: Skull Base
  • Publication Type: Research Article

Michael Bury | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Mr. Michael Bury | Medicine and Dentistry | Best Researcher Award

Academic Teacher at Poznan University of Medical Sciences, Poland

Michał Bury is a dedicated researcher in audiology and neurotology, currently a PhD student at Poznan University of Medical Sciences. With a strong academic foundation, including a master’s degree in Hearing Prosthetics and a bachelor’s in Audiophonology, he has quickly established himself in the field. His research focuses on tinnitus, vestibular disorders, and genetically conditioned auditory defects, contributing to multiple scientific publications in reputable journals such as J. Clin. Med. and Nowa Audiofonologia. He has presented his work at national and international conferences, earning distinctions and certificates for his contributions. As an assistant at multiple universities and a member of the Industry Competence Council under the Ministry of Health, he plays a key role in advancing hearing care. His commitment to interdisciplinary research and public health initiatives underscores his potential as an emerging leader in audiology. With further international collaborations and independent research leadership, his impact is set to grow.

Professional Profile 

Education

Michał Bury has a strong academic background in audiology and medical sciences. He is currently pursuing a PhD at the College of Medical and Health Sciences at Poznan University of Medical Sciences, further advancing his expertise in hearing prosthetics and neurotology. He earned his master’s degree in Hearing Prosthetics (2021-2023) from Poznan University of Medical Sciences, where he specialized in medical sciences with a focus on audiology. Prior to that, he completed a bachelor’s degree in Audiophonology (2018-2021) at Collegium Medicum of Ludwik Rydygier in Bydgoszcz, part of Nicolaus Copernicus University in Torun, with a concentration in health sciences. His academic journey reflects a strong commitment to research and innovation in hearing care. Through his studies, he has developed expertise in audiology, vestibular disorders, and hearing rehabilitation, equipping him with the knowledge and skills to contribute significantly to advancements in auditory health and prosthetics.

Professional Experience

Michał Bury has gained extensive professional experience in audiology, hearing prosthetics, and scientific research. Since October 2023, he has been an assistant at the Department of Hearing Prosthetics and Department of Biophysics at Poznan University of Medical Sciences, where he contributes to research and academic activities. He also holds a position as an assistant at Stanisław Staszic University of Applied Sciences in Piła and will join Adam Mickiewicz University in Poznań as an assistant in 2025. Previously, he worked as a Scientific and Technical Research Specialist at the Department of Biophysics (2022-2023), supporting research on auditory health. Additionally, he has practical experience as an Audiological and Otoneurological Diagnostician at MedSłuch Laboratory of Hearing and Balance Tests. His diverse roles highlight his expertise in both clinical and academic settings, demonstrating his dedication to advancing research and education in hearing science, audiology, and neurotology.

Research Interest

Michał Bury’s research interests focus on audiology, neurotology, and hearing care, with a particular emphasis on the diagnosis and rehabilitation of auditory disorders. His work explores the role of the vestibular and auditory systems in aging populations, tinnitus, and genetically conditioned hearing defects. He is also interested in hearing prosthetics and their application in rare diseases, as well as the co-occurrence of temporomandibular disorders in patients with tinnitus. His studies integrate medical sciences, health sciences, and biophysics to improve hearing diagnostics and rehabilitation strategies. Through his research, he aims to enhance clinical approaches to audiological and otoneurological conditions, contributing to advancements in patient care. His commitment to interdisciplinary collaboration and innovation in hearing prosthetics underscores his role in shaping the future of auditory health. By combining academic research with practical applications, he seeks to develop more effective treatments and interventions for individuals with hearing impairments.

Award and Honor

Michał Bury has received several awards and honors in recognition of his contributions to audiology and hearing research. He was awarded a certificate for presenting his paper, The Role of Vestibular and Auditory System Examination in the Elderly, at the Polish Society of Otolaryngologists, Head and Neck Surgeons Congress (UCHO 2024) in Warsaw. He also received a certificate for his presentation on Diagnosis and Rehabilitation of the Auditory System in Genetically Conditioned Defects at the 17th Scientific and Training Conference of the Audiology and Phoniatrics Section in Łódź. Additionally, he was honored with a certificate from the Minister of Health of Ukraine and the Rector of Bukovinian State Medical University for his research on otosclerosis. His academic achievements have also been recognized with a distinction from the Rector of Poznan University of Medical Sciences in a diploma thesis competition. These accolades highlight his growing impact in auditory sciences and medical research.

Research Skill

Michał Bury possesses strong research skills in audiology, neurotology, and hearing prosthetics, with expertise in both experimental and clinical studies. He is proficient in conducting systematic reviews and meta-analyses, as demonstrated in his publication on the co-occurrence of temporomandibular disorders and tinnitus. His ability to design and execute research studies is evident in his work on vestibular and auditory system examinations in elderly patients and genetically conditioned hearing defects. He is skilled in audiological diagnostics, data analysis, and interdisciplinary research, integrating medical sciences, biophysics, and health sciences. His experience in presenting research at national and international conferences reflects his ability to communicate complex findings effectively. Additionally, his involvement in hearing loss awareness programs and professional organizations demonstrates his capacity for applied research and innovation. With a growing publication record and a commitment to advancing auditory health, he continues to refine his research methodology and scientific contributions.

Conclusion

Michał Bury is a highly promising researcher with strong academic, scientific, and professional credentials in audiology and hearing prosthetics. His multiple publications, conference presentations, and industry memberships highlight his dedication to advancing the field. While he is still in the early stages of his PhD journey, his rapid progress and contributions already set him apart.

If the Best Researcher Award prioritizes early-career excellence, research output, and impact in audiology, he is a strong candidate. However, securing more leadership roles, international collaborations, and funding could further enhance his chances in future prestigious research awards.

Publications Top Noted

  • Bury, M., Nijakowski, K., Majewska, A., Jankowski, J., Surdacka, A., & Hojan-Jezierska, D. (2025). The Co-Occurrence of Temporomandibular Disorders in Patients Diagnosed with Tinnitus: A Systematic Review with Meta-Analysis. Journal of Clinical Medicine, 14(6), 1836. DOI: 10.3390/jcm14061836.

  • Bury, M., Frąszczak, P., & Kędziora-Kornatowska, K. (2020). The Functioning of the Patient in the Mental Aspect and Interpersonal Relationships After Laryngectomy Surgery. Journal of Education, Health and Sport, 10(9), 473-480. DOI: 10.12775/JEHS.2020.10.09.056.

Betül Kilincli | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Mrs. Betül Kilincli | Medicine and Dentistry | Best Researcher Award

PhD candidate at Adana Alparslan Turkes Science and Technology Universty, Turkey

Betul Kilincli is a dedicated researcher specializing in food engineering, biotechnology, and nanotechnology. Her expertise spans the production and characterization of functional food components, biosensors, and microfluidic applications. She has received multiple prestigious scholarships, including the BIDEB PhD Scholarship and the YOK 100/2000 PhD Scholarship. With a strong background in interdisciplinary research, she actively contributes to projects involving nanotechnology, food safety, and biomedical applications. Her work includes published research in high-impact journals and numerous conference presentations.

Professional Profile 

Education

Betul Kilincli is pursuing a Ph.D. in Food Engineering at Adana Alparslan Turkes Science and Technology University, focusing on proniosomal olive leaf extract powder. She earned her Master’s degree in Food Engineering from Cukurova University, where she researched Turkmen fringe cheese. Additionally, she completed pedagogical training at Mersin University and participated in the Farabi Exchange Program at Erciyes University. She holds a Bachelor’s degree in Food Engineering from Munzur University.

Professional Experience

Betul Kilincli has extensive experience in both industry and academia. She currently works as a researcher at the National Nanotechnology Research Center at Bilkent University, contributing to interdisciplinary projects. Previously, she was a food engineer at Oguz Food Industry and Canipek Food Production. She has been actively involved in grant applications, laboratory management, and experimental design. Her experience also includes mentoring students and conducting research on biosensors, food safety, and microfluidic applications.

Research Interests

Betul Kilincli’s research focuses on food engineering, biotechnology, and nanotechnology, with a particular emphasis on functional food components, biosensors, and microfluidic applications. She is deeply engaged in developing innovative approaches for food preservation, bioactive compound delivery, and food safety monitoring. Her work integrates advanced nanomaterials with food science to enhance the stability, bioavailability, and efficacy of bioactive ingredients. She is also interested in the applications of biosensors for detecting contaminants in food products and biomedical diagnostics.

Awards and Honors

Betul Kilincli has been recognized with several prestigious scholarships and awards for her contributions to food engineering and biotechnology. She received the BIDEB PhD Scholarship from TÜBİTAK, the YOK 100/2000 PhD Scholarship, and the International Research Scholarship from TÜBİTAK for her studies abroad. Additionally, she has been honored for her research presentations at international conferences and has contributed to high-impact scientific journals, showcasing her expertise and innovation.

Research Skills

Betul Kilincli possesses strong research skills in nanotechnology, biosensors, and microfluidics, along with expertise in analytical techniques such as FTIR, SEM, HPLC, and UV-Vis spectroscopy. She is proficient in formulating and characterizing functional food components, including nanoencapsulation and proniosome-based delivery systems. Her skills also extend to experimental design, data analysis, and grant writing. Additionally, she has experience working in multidisciplinary research teams, conducting laboratory experiments, and mentoring students in advanced food engineering and biotechnology projects.

Conclusion

Betul Kilincli is a highly qualified and accomplished researcher in the fields of food engineering, nanotechnology, and biotechnology. Her contributions in biosensors, microfluidics, and food safety research make her a strong candidate for the Best Researcher Award. With additional high-impact publications, global collaborations, and commercialization efforts, she could further strengthen her candidacy and influence in the scientific community.

Publications Top Noted

  • The risk estimation and assessment of heavy metal exposure by biomonitoring in the breast milk of mothers in the Cukurova Region, Turkey

    • Authors: E. Nazlıcan, E. Arıca, İ. E. Gören, B. Kılınçlı, B. Mete, N. Dağlıoğlu
    • Year: 2022
    • Citations: 9

  • Biosensor for ATP detection via aptamer-modified PDA@ POSS nanoparticles synthesized in a microfluidic reactor

    • Authors: G. Kibar, O. B. Şahinoğlu, B. Kılınçlı, E. Y. Erdem, B. Çetin, V. C. Özalp
    • Year: 2024
    • Citations: 7

  • Local Cheese Varieties in the Mediterranean Region

    • Authors: N. Güzeler, B. Kılınçlı
    • Year: 2018
    • Citations: 2

  • Microfluidic vs. batch synthesis of fluorescent poly (GMA-co-EGDMA) micro/nanoparticles for biomedical applications

    • Authors: B. Kılınçlı, A. D. Çınar, B. Çetin, G. Kibar
    • Year: 2024
    • Citations: Not available

  • Investigation of macroelement and mineral values in breast milk in the first six months postpartum

    • Authors: E. Nazlıcan, B. Kılınçlı, B. E. Yoldaşcan, N. Güzeler, A. R. Abdul-Aziz
    • Year: 2021
    • Citations: Not available

  • Süper Meyvelerin İnsan Sağlığı Üzerine Etkileri

    • Author: B. Kılınçlı
    • Year: 2020
    • Citations: Not available

  • Kars Ardahan illerinde üretilerek satışa sunulan Türkmen saçak peynirlerinin kalite özellikleri

    • Author: B. Kılınçlı
    • Year: 2019
    • Citations: Not available

  • Baby Nutrition and Industrial Baby Foods

    • Authors: F. Koboyeva, N. Güzeler, B. Kılınçlı, E. Kadir
    • Year: 2018
    • Citations: Not available

Liying Zhang | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Liying Zhang | Medicine and Dentistry | Best Researcher Award

Professor at University of California, Los Angeles, United States

Dr. Liying Zhang, MD, PhD, FACMG, is a distinguished researcher and professor specializing in molecular diagnostics and precision oncology. She serves as the Director of the Advanced Molecular Diagnostics Service at UCLA David Geffen School of Medicine and the Director of Cancer Molecular Diagnostics at UCLA Jonsson Comprehensive Cancer Center. With extensive experience in molecular genetics, her research focuses on cancer diagnostics, biomarker discovery, and precision medicine. She has contributed to numerous high-impact studies, secured significant research funding, and played an active role in national and international expert committees. Her expertise spans clinical molecular genetics, genomics, bioinformatics, and laboratory medicine, making her a leading figure in the field of cancer molecular diagnostics.

Professional Profile 

Education

Dr. Zhang earned her Ph.D. in Biochemistry and Molecular Biology from The Johns Hopkins University in 2003, alongside a Master’s degree in Computer Science with a focus on Bioinformatics in 2002. She obtained her MD from Peking University, Beijing, China, in 1994. She holds multiple clinical licensures and board certifications, including Clinical Molecular Genetics and Genomics from the American Board of Medical Genetics and Genomics. Her strong educational foundation in medicine, biochemistry, molecular biology, and computational science has equipped her with the interdisciplinary expertise required for advancing molecular diagnostics and precision medicine.

Professional Experience

Dr. Zhang has held several prestigious roles in molecular pathology and diagnostics. Since 2020, she has been a Professor and Director at UCLA, leading advanced molecular diagnostics initiatives. Previously, she served as a Director and Molecular Geneticist at Memorial Sloan Kettering Cancer Center from 2005 to 2019, overseeing diagnostic molecular genetics laboratories and contributing to groundbreaking cancer research. Her earlier roles include research positions at the National Research Institute for Family Planning in China. Additionally, she has been actively involved in professional committees, journal reviews, and mentorship programs, furthering advancements in molecular diagnostics and genetic research.

Research Interest

Dr. Liying Zhang’s research focuses on molecular diagnostics, cancer genomics, and precision oncology. She is dedicated to identifying genetic biomarkers that enhance cancer detection, prognosis, and treatment strategies. Her work involves integrating next-generation sequencing (NGS) technologies, bioinformatics, and molecular pathology to improve the accuracy and efficiency of cancer diagnostics. She is particularly interested in the molecular mechanisms underlying tumor development, drug resistance, and targeted therapies. Through collaborations with oncologists, geneticists, and data scientists, she aims to translate genetic findings into clinically actionable insights that improve patient outcomes. Her research also extends to liquid biopsy, epigenetics, and the development of novel molecular assays for early cancer detection.

Awards and Honors

Dr. Zhang has received numerous prestigious awards recognizing her contributions to molecular genetics and cancer diagnostics. She has been honored as a Fellow of the American College of Medical Genetics and Genomics (FACMG), acknowledging her leadership and expertise in clinical molecular genetics. She has also received research excellence awards from institutions such as Memorial Sloan Kettering Cancer Center and UCLA for her groundbreaking work in cancer molecular diagnostics. Additionally, she has been an invited speaker at leading international conferences, including the American Society of Human Genetics (ASHG) and the Association for Molecular Pathology (AMP). Her contributions to scientific research and clinical practice have earned her recognition as a thought leader in precision medicine and molecular oncology.

Research Skills

Dr. Zhang possesses a diverse range of research skills in molecular diagnostics and genomics. She is proficient in next-generation sequencing (NGS) technologies, whole-genome and transcriptome analysis, and single-cell sequencing. She has extensive experience in bioinformatics, data mining, and computational modeling for genetic variant interpretation. Her expertise includes designing and validating molecular assays for clinical diagnostics, including PCR-based and hybrid capture-based sequencing methods. She is also skilled in laboratory management, regulatory compliance, and quality control in clinical molecular genetics laboratories. Additionally, her strong background in translational research allows her to bridge the gap between basic scientific discoveries and clinical applications, ensuring that her findings have a direct impact on patient care and personalized treatment strategies.

Conclusion

Dr. Liying Zhang is highly suitable for the Best Researcher Award due to her exceptional contributions to molecular diagnostics, cancer genomics, and precision medicine. Her extensive experience in research leadership, grant acquisition, and clinical applications makes her an outstanding candidate. Strengthening her independent research leadership and international collaborations would further solidify her candidacy for this prestigious award.

Publications Top Noted

  • Title: Inherited DNA-repair gene mutations in men with metastatic prostate cancer
    Authors: CC Pritchard, J Mateo, MF Walsh, N De Sarkar, W Abida, H Beltran, …
    Year: 2016
    Citation: 1765

  • Title: Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer
    Authors: L Klotz, L Zhang, A Lam, R Nam, A Mamedov, A Loblaw
    Year: 2010
    Citation: 1402

  • Title: Long-term follow-up of a large active surveillance cohort of patients with prostate cancer
    Authors: L Klotz, D Vesprini, P Sethukavalan, V Jethava, L Zhang, S Jain, …
    Year: 2015
    Citation: 1399

  • Title: CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct
    Authors: IYL Tan, AM Demchuk, J Hopyan, L Zhang, D Gladstone, K Wong, …
    Year: 2009
    Citation: 792

  • Title: Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
    Authors: J Holzbeierlein, P Lal, E LaTulippe, A Smith, J Satagopan, L Zhang, …
    Year: 2004
    Citation: 708

  • Title: Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer
    Authors: A Latham, P Srinivasan, Y Kemel, J Shia, C Bandlamudi, D Mandelker, …
    Year: 2019
    Citation: 591

  • Title: Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making
    Authors: W Abida, J Armenia, A Gopalan, R Brennan, M Walsh, D Barron, D Danila, …
    Year: 2017
    Citation: 583

  • Title: Celiac disease: summary
    Authors: A Rostom, C Dubé, A Cranney, N Saloojee, R Sy, C Garritty, M Sampson, …
    Year: 2004
    Citation: 511

  • Title: Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing
    Authors: D Mandelker, L Zhang, Y Kemel, ZK Stadler, V Joseph, A Zehir, …
    Year: 2017
    Citation: 508

  • Title: Tumour lineage shapes BRCA-mediated phenotypes
    Authors: P Jonsson, C Bandlamudi, ML Cheng, P Srinivasan, SS Chavan, …
    Year: 2019
    Citation: 384

  • Title: Hereditary diffuse gastric cancer: updated clinical practice guidelines
    Authors: VR Blair, M McLeod, F Carneiro, DG Coit, JL D’Addario, JM van Dieren, …
    Year: 2020
    Citation: 381

  • Title: Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases
    Authors: E Chow, P Hoskin, G Mitera, L Zeng, S Lutz, D Roos, C Hahn, …
    Year: 2012
    Citation: 374

  • Title: Reliable pan-cancer microsatellite instability assessment by using targeted next-generation sequencing data
    Authors: S Middha, L Zhang, K Nafa, G Jayakumaran, D Wong, HR Kim, …
    Year: 2017
    Citation: 363

  • Title: Genetic predictors of response to systemic therapy in esophagogastric cancer
    Authors: YY Janjigian, F Sanchez-Vega, P Jonsson, WK Chatila, JF Hechtman, …
    Year: 2018
    Citation: 352